|
JP2002512594A
(ja)
*
|
1996-12-11 |
2002-04-23 |
ファーマサイクリックス，インコーポレイテッド |
眼の診断および治療におけるテキサフィリンの使用
|
|
US6270749B1
(en)
|
1996-12-11 |
2001-08-07 |
Pharmacyclics, Inc. |
Use of Texaphyrin in ocular diagnosis and therapy
|
|
CA2279427C
(en)
*
|
1997-02-11 |
2009-11-24 |
Qlt Phototherapeutics, Inc. |
Use of low dose photodynamic therapy for reducing the effects of inflammation
|
|
US6274614B1
(en)
|
1997-02-11 |
2001-08-14 |
Qlt Inc. |
Methods, compositions and articles for reducing or preventing the effects of inflammation
|
|
ATE267215T1
(de)
|
1997-12-08 |
2004-06-15 |
Lexigen Pharm Corp |
Heterodimäre fusionsproteine zur verwendung für gezielte immuntherapie und allgemeine immunerregung
|
|
US6117862A
(en)
*
|
1998-10-09 |
2000-09-12 |
Qlt, Inc. |
Model and method for angiogenesis inhibition
|
|
US7022843B1
(en)
|
1999-04-14 |
2006-04-04 |
The University Of British Columbia |
β,β′-dihydroxy meso-substituted chlorins, isobacteriochlorins, and bacteriochlorins
|
|
US20020022032A1
(en)
*
|
1999-04-23 |
2002-02-21 |
Curry Patrick Mark |
Immuno-adjuvant PDT treatment of metastatic tumors
|
|
US7067110B1
(en)
|
1999-07-21 |
2006-06-27 |
Emd Lexigen Research Center Corp. |
Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens
|
|
ATE316982T1
(de)
|
1999-08-09 |
2006-02-15 |
Lexigen Pharm Corp |
Mehrere zytokin-antikörper komplexen
|
|
JP2003514552A
(ja)
|
1999-11-12 |
2003-04-22 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング |
改善された性質を有するエリトロポエチンの形態
|
|
US6443976B1
(en)
|
1999-11-30 |
2002-09-03 |
Akorn, Inc. |
Methods for treating conditions and illnesses associated with abnormal vasculature
|
|
US6534040B2
(en)
|
1999-12-23 |
2003-03-18 |
Health Research, Inc. |
Chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
|
|
US7097826B2
(en)
|
1999-12-23 |
2006-08-29 |
Health Research, Inc. |
Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
|
|
US7897140B2
(en)
|
1999-12-23 |
2011-03-01 |
Health Research, Inc. |
Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
|
|
US7078014B2
(en)
*
|
1999-12-23 |
2006-07-18 |
Health Research, Inc. |
Method for using chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
|
|
WO2001051087A2
(en)
*
|
2000-01-12 |
2001-07-19 |
Light Sciences Corporation |
Novel treatment for eye disease
|
|
AU2006203034B2
(en)
*
|
2000-02-10 |
2006-09-07 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for treating conditions of the eye
|
|
DE60135633D1
(de)
*
|
2000-02-10 |
2008-10-16 |
Massachusetts Eye & Ear Infirm |
Photodynamische therapie zur behandlung von augenerkrankungen
|
|
AU4314801A
(en)
|
2000-02-11 |
2001-08-20 |
Lexigen Pharm Corp |
Enhancing the circulating half-life of antibody-based fusion proteins
|
|
IL151833A0
(en)
*
|
2000-03-24 |
2003-04-10 |
Novartis Ag |
Improved treatment of neovascularization
|
|
PL358582A1
(en)
|
2000-06-29 |
2004-08-09 |
Merck Patent Gmbh |
Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents
|
|
US20030082183A1
(en)
*
|
2000-11-01 |
2003-05-01 |
Wheeler Larry A. |
Methods and compositions for treatment of ocular neovascularization and neural injury
|
|
AU2002248284A1
(en)
*
|
2000-11-01 |
2002-08-06 |
Allergan, Inc. |
Compositions for treatment of ocular neovascularization
|
|
CA2437557C
(en)
|
2001-02-06 |
2012-07-24 |
Qlt Inc. |
Reduced total fluence photodynamic therapy of choroidal neovasculature in amd
|
|
US7753943B2
(en)
*
|
2001-02-06 |
2010-07-13 |
Qlt Inc. |
Reduced fluence rate PDT
|
|
US8106038B2
(en)
|
2001-02-15 |
2012-01-31 |
Qlt Inc. |
Method for reducing or preventing PDT related inflammation
|
|
RU2003129528A
(ru)
|
2001-03-07 |
2005-04-10 |
Мерк Патент ГмбХ (DE) |
Способ экспрессии белков, содержащих в качестве компонента гибридный изотип антитела
|
|
US6992174B2
(en)
|
2001-03-30 |
2006-01-31 |
Emd Lexigen Research Center Corp. |
Reducing the immunogenicity of fusion proteins
|
|
MXPA03009924A
(es)
|
2001-05-03 |
2004-01-29 |
Merck Patent Gmbh |
Anticuerpo recombinante especifico de tumor y uso del mismo.
|
|
WO2003007944A1
(en)
*
|
2001-07-20 |
2003-01-30 |
Qlt, Inc. |
Treatment of macular edema with photodynamic therapy
|
|
AP1750A
(en)
*
|
2001-11-09 |
2007-06-23 |
Eyetech Pharmaceuticals |
Methods for treating ocular neovascular diseases
|
|
DK1454138T3
(da)
|
2001-12-04 |
2012-02-13 |
Merck Patent Gmbh |
Immunocytokiner med moduleret selektivitet
|
|
EP1467760A2
(en)
*
|
2002-01-23 |
2004-10-20 |
Light Sciences Corporation |
Systems and methods for photodynamic therapy
|
|
AU2003215458B2
(en)
*
|
2002-03-20 |
2008-05-29 |
Novadaq Technologies Inc. |
System and method for visualizing fluid flow through vessels
|
|
JP2005532393A
(ja)
*
|
2002-07-02 |
2005-10-27 |
ザ・リージェンツ・オブ・ジ・ユニバーシティ・オブ・カリフォルニア |
眼の障害についての処置
|
|
US7364574B2
(en)
*
|
2002-07-17 |
2008-04-29 |
Novadaq Technologies Inc. |
Combined photocoagulation and photodynamic therapy
|
|
CN1708266A
(zh)
*
|
2002-10-03 |
2005-12-14 |
光科学公司 |
用于眼组织中光反应化合物的激发的系统和方法
|
|
AU2003301267A1
(en)
*
|
2002-10-18 |
2004-05-04 |
The Regents Of The University Of California |
Photodynamic therapy for ocular neovascularization
|
|
EP1572748B1
(en)
|
2002-12-17 |
2010-06-23 |
MERCK PATENT GmbH |
Humanized antibody (h14.18) of the mouse 14.18 antibody binding to gd2 and its fusion with il-2
|
|
WO2004073492A2
(en)
*
|
2003-02-14 |
2004-09-02 |
Massachusetts Eye And Ear Infirmary |
Chlamydia pneumoniae associated chronic intraocular disorders and treatment thereof
|
|
CA2530166A1
(en)
*
|
2003-03-07 |
2004-09-23 |
Randolph D. Glickman |
Antibody-targeted photodynamic therapy
|
|
US20040220167A1
(en)
*
|
2003-05-02 |
2004-11-04 |
Nasrollah Samiy |
Methods of treating neuralgic pain
|
|
CA2525447C
(en)
*
|
2003-05-14 |
2013-08-06 |
Universite De Sherbrooke |
Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine
|
|
CN100534428C
(zh)
*
|
2003-08-25 |
2009-09-02 |
上海复旦张江生物医药股份有限公司 |
血卟啉单甲醚在治疗眼科疾病中的应用
|
|
US20050048109A1
(en)
*
|
2003-08-26 |
2005-03-03 |
Ceramoptec Industries, Inc. |
Non-polar photosensitizer formulations for photodynamic therapy
|
|
DK1699822T3
(da)
|
2003-12-30 |
2008-08-04 |
Merck Patent Gmbh |
IL-7-fusionsproteiner med antistofdele, fremstilling deraf og anvendelse deraf
|
|
JP2008504008A
(ja)
|
2003-12-31 |
2008-02-14 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング |
改良された薬物動態を有するＦｃ−エリスロポエチン融合タンパク質
|
|
EP1702069A2
(en)
|
2004-01-05 |
2006-09-20 |
EMD Lexigen Research Center Corp. |
Interleukin-12 targeted to oncofoetal fibronectin
|
|
US20050244466A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Photodynamic therapy in conjunction with intraocular implants
|
|
US7727544B2
(en)
*
|
2004-05-07 |
2010-06-01 |
The Regents Of The University Of California |
Treatment of myopia
|
|
WO2006020979A2
(en)
*
|
2004-08-13 |
2006-02-23 |
Yale University |
Factor vii conjugates for selectively treating neovascularization disorders
|
|
JP2008510529A
(ja)
*
|
2004-08-27 |
2008-04-10 |
エレックス メディカル プロプライエタリー リミテッド |
選択的眼科レーザ治療
|
|
WO2006036176A1
(en)
*
|
2004-09-24 |
2006-04-06 |
Light Sciences Corporation |
Extended treatment of tumors through vessel occlusion with light activated drugs
|
|
CA2588423A1
(en)
*
|
2004-11-17 |
2006-05-26 |
Joanne Mclaurin |
Compositions comprising scyllo-inositol derivatives and methods to treat disorders of protein aggregation
|
|
DE602005020837D1
(de)
|
2004-12-09 |
2010-06-02 |
Merck Patent Gmbh |
Il-7-varianten mit reduzierter immunogenität
|
|
WO2006065727A1
(en)
*
|
2004-12-15 |
2006-06-22 |
Light Sciences Corporation |
Enhanced occlusive effect photodynamic therapy
|
|
WO2006091666A2
(en)
*
|
2005-02-23 |
2006-08-31 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for treating conditions of the eye
|
|
US20070122344A1
(en)
|
2005-09-02 |
2007-05-31 |
University Of Rochester Medical Center Office Of Technology Transfer |
Intraoperative determination of nerve location
|
|
CA2626005A1
(en)
*
|
2005-10-13 |
2007-10-25 |
Waratah Pharmaceuticals Inc. |
Inositol derivatives and their uses in the treatment of diseases characterized by abnormal protein folding or aggregation or amyloid formation, deposition, accumulation or persistence
|
|
US8658633B2
(en)
*
|
2006-02-16 |
2014-02-25 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for treating conditions of the eye
|
|
WO2007097961A1
(en)
*
|
2006-02-16 |
2007-08-30 |
Massachusetts Eye & Ear Infirmary |
Use of azurocidin inhibitors in prevention and treatment of ocular vascular leakage
|
|
US20070197452A1
(en)
*
|
2006-02-17 |
2007-08-23 |
Mclaurin Joanne |
Treatment of amyloid-related diseases
|
|
WO2007129221A2
(en)
*
|
2006-02-17 |
2007-11-15 |
Waratah Parmaceuticals Inc |
Compositions comprising an epi-inositol compounds and methods for treatment of disorders of protein aggregation
|
|
CN103054837A
(zh)
*
|
2006-03-09 |
2013-04-24 |
瓦拉塔药品公司 |
用于治疗蛋白积聚病症的环己烷多元醇制剂
|
|
US20110028719A1
(en)
*
|
2006-05-19 |
2011-02-03 |
Jacek Slon-Usakiewicz |
Screening methods for amyloid beta modulators
|
|
US20080161744A1
(en)
|
2006-09-07 |
2008-07-03 |
University Of Rochester Medical Center |
Pre-And Intra-Operative Localization of Penile Sentinel Nodes
|
|
US20100173960A1
(en)
*
|
2006-09-21 |
2010-07-08 |
Antonio Cruz |
The Combination of a Cyclohexanehexol and a NSAID for the Treatment of Neurodegenerative Diseases
|
|
AU2007308749B2
(en)
|
2006-10-25 |
2013-02-14 |
Alpharet Pty Ltd |
Retinal regeneration
|
|
EP2091566A4
(en)
*
|
2006-11-24 |
2011-07-06 |
Waratah Pharmaceuticals Inc |
COMBINATION THERAPIES AGAINST ALZHEIMER DISEASE AND SIMILAR ILLNESSES
|
|
US7972787B2
(en)
*
|
2007-02-16 |
2011-07-05 |
Massachusetts Eye And Ear Infirmary |
Methods for detecting age-related macular degeneration
|
|
US20110105626A1
(en)
*
|
2007-04-12 |
2011-05-05 |
Mclaurin Joanne |
Use of cyclohexanehexol derivatives for the treatment of polyglutamine diseases
|
|
CA2683546A1
(en)
*
|
2007-04-12 |
2008-10-23 |
Joanne Mclaurin |
Use of cyclohexanehexol derivatives in the treatment of .alpha.-synucleinopathies
|
|
US20100144891A1
(en)
*
|
2007-04-12 |
2010-06-10 |
Mclaurin Joanne |
Use of cyclohexanehexol derivatives in the treatment of amyotrophic lateral sclerosis
|
|
HRP20130768T1
(en)
|
2007-04-12 |
2013-10-25 |
Waratah Pharmaceuticals, Inc. |
Use of cyclohexanehexol derivatives in the treatment of ocular diseases
|
|
JP5656627B2
(ja)
*
|
2007-05-30 |
2015-01-21 |
エレックス アールアンドディー プロプライエタリー リミテッドＥｌｌｅｘ Ｒ＆Ｄ Ｐｔｙ Ｌｔｄ |
網膜活性化レーザ装置
|
|
US20090170770A1
(en)
*
|
2007-11-06 |
2009-07-02 |
Ali Hafezi-Moghadam |
Methods and compositions for treating conditions associated with angiogenesis using a vascular adhesion protein-1 (vap 1) inhibitor
|
|
US8406860B2
(en)
|
2008-01-25 |
2013-03-26 |
Novadaq Technologies Inc. |
Method for evaluating blush in myocardial tissue
|
|
WO2009126894A2
(en)
*
|
2008-04-11 |
2009-10-15 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for the diagnosis and treatment of angiogenic disorders
|
|
US10219742B2
(en)
|
2008-04-14 |
2019-03-05 |
Novadaq Technologies ULC |
Locating and analyzing perforator flaps for plastic and reconstructive surgery
|
|
EP3372250B1
(en)
|
2008-05-02 |
2019-12-25 |
Novadaq Technologies ULC |
Methods for production and use of substance-loaded erythrocytes for observation and treatment of microvascular hemodynamics
|
|
CA2740124A1
(en)
*
|
2008-10-09 |
2010-04-15 |
Waratah Pharmaceuticals Inc. |
Use of scyllo-inositols for the treatment of macular degeneration-related disorders
|
|
KR101018785B1
(ko)
*
|
2008-11-28 |
2011-03-03 |
삼성전기주식회사 |
전자기 밴드갭 구조물 및 회로 기판
|
|
SG175233A1
(en)
|
2009-04-22 |
2011-11-28 |
Merck Patent Gmbh |
Antibody fusion proteins with modified fcrn binding sites
|
|
US10492671B2
(en)
|
2009-05-08 |
2019-12-03 |
Novadaq Technologies ULC |
Near infra red fluorescence imaging for visualization of blood vessels during endoscopic harvest
|
|
WO2012040619A2
(en)
|
2010-09-24 |
2012-03-29 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for prognosing and/or detecting age-related macular degeneration
|
|
JP6215203B2
(ja)
|
2011-08-23 |
2017-10-18 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドＹｅｄａ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｄｅｖｅｌｏｐｍｅｎｔ Ｃｏ． Ｌｔｄ |
眼疾患および障害の治療用の（バクテリオ）クロロフィル光増感剤
|
|
US9211214B2
(en)
|
2012-03-21 |
2015-12-15 |
Valeant Pharmaceuticals International, Inc |
Photodynamic therapy laser
|
|
EP2863801B8
(en)
|
2012-06-21 |
2024-06-12 |
Stryker Corporation |
Quantification and analysis of angiography and perfusion
|
|
US9962251B2
(en)
|
2013-10-17 |
2018-05-08 |
Boston Scientific Scimed, Inc. |
Devices and methods for delivering implants
|
|
US9816930B2
(en)
|
2014-09-29 |
2017-11-14 |
Novadaq Technologies Inc. |
Imaging a target fluorophore in a biological material in the presence of autofluorescence
|
|
CA2963450A1
(en)
|
2014-10-09 |
2016-04-14 |
Novadaq Technologies Inc. |
Quantification of absolute blood flow in tissue using fluorescence-mediated photoplethysmography
|
|
CN106620893B
(zh)
|
2015-07-23 |
2021-07-30 |
爱博诺德(北京)医疗科技股份有限公司 |
用于眼部疾病光治疗的材料
|
|
US10925869B2
(en)
|
2016-05-26 |
2021-02-23 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Compositions and methods for treating pulmonary vascular disease
|
|
EP4242743A3
(en)
|
2017-02-10 |
2023-10-18 |
Stryker European Operations Limited |
Open-field handheld fluorescence imaging systems and methods
|
|
KR20190056758A
(ko)
|
2017-11-17 |
2019-05-27 |
주식회사 지뉴브 |
종양줄기세포 특성의 암을 치료하기 위한 항암 병용 요법
|